AssetMemo
AssetsMechanismsCompaniesCalendarChartsWatchlistAsk AIMethodology
  • Cardiovascular & Metabolic469
  • Dermatology230
  • Gastroenterology & Hepatology177
  • Hematology45
  • Immunology176
  • Infectious Disease145
  • Nephrology130
  • Neurology478
  • Oncology1,186
  • Ophthalmology75
  • Psychiatry141
  • Rare & Genetic Diseases141
  • Respiratory162
◧AssetMemo
⌕

Evidence-graded drug-asset intelligence
◧AssetMemo
AssetsMechanismsCompaniesReadout CalendarCompare ChartsWatchlist & AlertsAsk AI
Therapeutic areas
  • Cardiovascular & Metabolic469
  • Dermatology230
  • Gastroenterology & Hepatology177
  • Hematology45
  • Immunology176
  • Infectious Disease145
  • Nephrology130
  • Neurology478
  • Oncology1,186
  • Ophthalmology75
  • Psychiatry141
  • Rare & Genetic Diseases141
  • Respiratory162
ReferenceMethodology & RubricUs vs. AI ToolsUK IBD Access GuideAbout the founder

Educational data tool. Evidence graded; securities never are.

BrowseAll assetsAll mechanismsAll companiesReadout calendarReadouts by yearResults by diseaseDelayed readoutsOpen dataCompare share pricesWhat's new
ReferenceMethodology & sourcesUs vs. the AI toolsUK IBD Access GuideAbout the founderAsk the AIReport a problem / suggest a feature

Educational research only, not investment advice. Evidence quality is graded; securities never are. · Terms · Privacy · Logos by Logo.dev

Ask

Opening the console…

Companies with late-stage small molecules

309 companies hold rights to 358 small molecules (small-molecule drugs, including targeted protein degraders) that are in Phase 3, Phase 2/3 or filed for approval. Sorted by the number of such drugs, then by name. Approved drugs are not counted. The full directory, with financials, is on the companies page.

BiologicsSmall moleculesCell and gene therapiesRNA and oligonucleotide drugsPeptide drugs
Late-stage small molecules, by developer
CompanyTickerLate-stageDrugs (stage, indications)
Jiangsu Hengrui Pharmaceuticals60027620Apatinib (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma); Dalpiciclib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Famitinib (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer); Fluzoparib (Phase 3, Metastatic Castration-Resistant Prostate Cancer); Henagliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease); Hetrombopag (Phase 3, Chemotherapy-Induced Thrombocytopenia); HRG2010 (Phase 3, Parkinson's Disease); HRS-1780 (Phase 3, Chronic Kidney Disease); HRS-6209 (Phase 3, HR+/HER2- Metastatic Breast Cancer); HRS-8080 (Phase 3, HR+/HER2- Metastatic Breast Cancer); HRS-8427 (Phase 3, Complicated Urinary Tract Infection); ivarmacitinib (Phase 3, Non-Radiographic Axial Spondyloarthritis); Plinabulin (Phase 3, Non-Small Cell Lung Cancer); Pyrotinib (Phase 3, Non-Small Cell Lung Cancer, HER2-Positive Breast Cancer); Retagliptin (Phase 3, Type 2 Diabetes); Rezvilutamide (Phase 3, Prostate Cancer); RSS0393 (Phase 3, Atopic Dermatitis, Psoriasis); Safiglipron (HRS-7535) (Phase 3, Obesity, Type 2 Diabetes, Hypertension and more); SHR-6209 (Phase 3, HR+/HER2- Metastatic Breast Cancer); SHR6508 (Phase 3, Chronic Kidney Disease)
AstraZenecaAZN12Balcinrenone (Phase 3, Heart Failure, Chronic Kidney Disease); Ceralasertib (Phase 3); elecoglipron (Phase 3, Obesity, Type 2 Diabetes, Heart Failure and more); Laroprovstat (Phase 3, Atherosclerotic Cardiovascular Disease, Dyslipidemia); laroprovstat/rosuvastatin (Phase 3, Atherosclerotic Cardiovascular Disease); Roxadustat (Phase 3, Chronic Kidney Disease, Myelodysplastic Syndromes); Saruparib (Phase 3, HR+/HER2- Metastatic Breast Cancer, Prostate Cancer); Savolitinib (Phase 3, Non-Small Cell Lung Cancer, Renal Cell Carcinoma); Sodium zirconium cyclosilicate (Phase 3, Chronic Kidney Disease); TQC3721 (Phase 3, Chronic Obstructive Pulmonary Disease); Zibotentan + Dapagliflozin (Phase 3, Chronic Kidney Disease); Glycopyrronium (PT001) (Phase 2/3, Asthma)
Merck & Co.MRK9Alimatravir (Phase 3, HIV, HIV Pre-Exposure Prophylaxis); Bomedemstat (Phase 3, Essential Thrombocythemia); Calderasib (Phase 3, Non-Small Cell Lung Cancer); Islatravir (Phase 3, HIV); Islatravir/lenacapavir (Phase 3, HIV); Nemtabrutinib (Phase 3, Chronic Lymphocytic Leukemia); Omarigliptin (Phase 3); Opevesostat (Phase 3, Metastatic Castration-Resistant Prostate Cancer); Ulonivirine (Phase 2/3, HIV)
Boehringer Ingelheim—7Apecotrep (Phase 3, Chronic Kidney Disease, Focal Segmental Glomerulosclerosis); fenoterol (Phase 3, Asthma); fenoterol/ipratropium bromide (Phase 3, Asthma); Ifebemtinib (Phase 3, Non-Small Cell Lung Cancer); Nintedanib (Vargatef) (Phase 3, Non-Small Cell Lung Cancer); Oxitropium bromide (Ba253BINEB) (Phase 3, Asthma); Vicadrostat (Phase 3, Type 2 Diabetes, Hypertension, Heart Failure and more)
PfizerPFE7alprostadil (Phase 3, Heart Failure, Atherosclerotic Cardiovascular Disease); Atirmociclib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Esreboxetine (Phase 3, Fibromyalgia); Ibuzatrelvir (Phase 3, COVID-19); Mevrometostat (Phase 3, Metastatic Castration-Resistant Prostate Cancer); Prifetrastat (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer); Reboxetine (Phase 3, Narcolepsy)
RocheRHHBY7bexobrutideg (Phase 3, Chronic Lymphocytic Leukemia, Relapsed/Refractory Chronic Lymphocytic Leukemia); Bitopertin (Phase 3, Erythropoietic Protoporphyria); Divarasib (Phase 3, Non-Small Cell Lung Cancer); Fenebrutinib (Phase 3, Multiple Sclerosis); Giredestrant (Phase 3, HR+/HER2- Metastatic Breast Cancer); Bizrolertinib (Phase 2/3, HER2-Positive Breast Cancer); Elsulfavirine (Phase 2/3, HIV)
Takeda Pharmaceutical CompanyTAK7Mitiglinide (Phase 3, Type 2 Diabetes); Omega-3-acid ethyl esters 90 (Lotriga) (Phase 3); Osavampator (Phase 3, Major Depressive Disorder); Trelagliptin (Phase 3, Type 2 Diabetes); Voglibose (Phase 3, Type 2 Diabetes); zasocitinib (Phase 3, Psoriatic Arthritis, Psoriasis, Vitiligo and more); TAK-360 (Phase 2/3, Narcolepsy)
CSPC Pharmaceutical Group10935Ammoxetine (Phase 3, Major Depressive Disorder); Levamlodipine/valsartan (SYH9056) (Phase 3, Hypertension); Prusogliptin (Phase 3, Type 2 Diabetes); Ruserontinib (Phase 3, Acute Myeloid Leukemia); SYHX1901 (Phase 3, Psoriasis)
Hansoh Pharmaceutical Group36925Almonertinib (Phase 3, Non-Small Cell Lung Cancer); HS-10374 (Phase 3, Psoriatic Arthritis, Psoriasis); HS-10380 (Phase 3, Schizophrenia); SHR6508 (Phase 3, Chronic Kidney Disease); Tenofovir amibufenamide (Hengmu) (Phase 3, Chronic Hepatitis B)
NovartisNVS5Afuresertib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Ganaplacide/lumefantrine (Phase 3, Malaria); Vildagliptin (Phase 3, Type 2 Diabetes); Votoplam (Phase 3, Huntington's Disease); Zoledronic acid (Phase 3, HR+/HER2- Metastatic Breast Cancer)
Qilu Pharmaceutical—5Afuresertib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Cariprazine (QLM1016) (Phase 3, Schizophrenia); Iruplinalkib (Phase 3, Non-Small Cell Lung Cancer); Olanzapine/samidorphan (Qilu) (Phase 3, Schizophrenia); QLM3003 (Phase 3, Atopic Dermatitis)
Sino Biopharmaceutical11775Culmerciclib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Garsorasib (Phase 3, Non-Small Cell Lung Cancer); NTQ1062 (Phase 3, HR+/HER2- Metastatic Breast Cancer); TQC3721 (Phase 3, Chronic Obstructive Pulmonary Disease); TQH3906 (Phase 3, Ulcerative Colitis, Crohn's Disease, Psoriatic Arthritis and more)
Taiho Pharmaceutical—5Casdatifan (Phase 3, Clear Cell Renal Cell Carcinoma); Glumetinib (Phase 3, Non-Small Cell Lung Cancer); Quemliclustat (Phase 3, Pancreatic Ductal Adenocarcinoma); S-1 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer, Gastric Cancer); Zipalertinib (Phase 3, Non-Small Cell Lung Cancer)
A. Menarini—4Mirogabalin (Phase 3, Diabetic Peripheral Neuropathic Pain); Obicetrapib (Phase 3, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, Early Alzheimer's Disease); Obicetrapib/ezetimibe (Evlarco) (Phase 3, Atherosclerotic Cardiovascular Disease); Ranolazine (Phase 3, Atherosclerotic Cardiovascular Disease)
Bristol-Myers SquibbBMY4Danicamtiv (Phase 3, Heart Failure); Golcadomide (Phase 3, Large B-Cell Lymphoma); Mezigdomide (Phase 3, Multiple Myeloma); Navlimetostat (Phase 2/3, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma)
Daewoong Pharmaceutical0696204DWC202206 + DWC202207 (Phase 3, Hypertension, Atherosclerotic Cardiovascular Disease); Enavogliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease); Gemigliptin (Phase 3, Type 2 Diabetes); Olmesartan/rosuvastatin (DWJ1276) (Phase 3, Hypertension)
Eli LillyLLY4Muvalaplin (Phase 3, Atherosclerotic Cardiovascular Disease); Olomorasib (Phase 3, Non-Small Cell Lung Cancer); Tersolisib (Phase 3, HR+/HER2- Metastatic Breast Cancer, Breast Cancer); Cleminorexton (Phase 2/3, Narcolepsy)
GlaxoSmithKlineGSK4neladalkib (Phase 3, Non-Small Cell Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer); Salbutamol HFA-152a (Phase 3, Asthma); Velzatinib (Phase 3, Gastrointestinal Stromal Tumor); Vilanterol (Phase 3, Asthma)
Haisco Pharmaceutical Group0026534Cofrogliptin (Phase 3, Type 2 Diabetes); Crisugabalin (Phase 3, Diabetic Peripheral Neuropathic Pain); HSK39004 (Phase 3, Chronic Obstructive Pulmonary Disease); HSK44459 (Phase 3, Atopic Dermatitis, Psoriasis, Idiopathic Pulmonary Fibrosis)
InventisBio6883824Befotertinib (Phase 3, Non-Small Cell Lung Cancer); Garsorasib (Phase 3, Non-Small Cell Lung Cancer); Nomelcitinib (D-2570) (Phase 3, Ulcerative Colitis, Psoriasis, Systemic Lupus Erythematosus and more); Taragarestrant (Phase 3, HR+/HER2- Metastatic Breast Cancer)
Johnson & JohnsonJNJ4bleximenib (Phase 3, Acute Myeloid Leukemia); Deulumateperone (Phase 3, Alzheimer's Disease, Alzheimer's Disease Agitation, Generalized Anxiety Disorder); JNJ-101556143 (Phase 3, Prostate Cancer); Seltorexant (Phase 3, Alzheimer's Disease, Major Depressive Disorder)
JW Pharmaceutical0010604Anagliptin (Phase 3, Type 2 Diabetes); Enarodustat (Phase 3, Chronic Kidney Disease); JW0201 (Phase 3, Type 2 Diabetes); Mitiglinide (Phase 3, Type 2 Diabetes)
SanofiSNY4Gemigliptin (Phase 3, Type 2 Diabetes); Tolebrutinib (Phase 3, Multiple Sclerosis); Venglustat (GZ/SAR402671) (Phase 3, Gaucher Disease); Elenestinib (Phase 2/3, Systemic Mastocytosis)
Tanabe Pharma Corporation—4AST-120 (Phase 3, Chronic Kidney Disease); Obicetrapib (Phase 3, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, Early Alzheimer's Disease); Sarpogrelate (Phase 3, Atherosclerotic Cardiovascular Disease); Teneligliptin (Phase 3, Type 2 Diabetes)
Allist Pharmaceuticals6885783Furmonertinib (Phase 3, Non-Small Cell Lung Cancer); Glecirasib (Phase 3, Non-Small Cell Lung Cancer); Sitneprotafib (Phase 3, Non-Small Cell Lung Cancer)
Ascentage Pharma Group Inc.AAPG3APG-2449 (Phase 3, Non-Small Cell Lung Cancer, Ovarian Cancer); Lisaftoclax (Phase 3, Acute Myeloid Leukemia, Multiple Myeloma, Systemic Lupus Erythematosus and more); Olverembatinib (Phase 3, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Myeloid Leukemia with T315I Mutation)
Astellas Pharma45033Bixalomer (Phase 3, Chronic Kidney Disease, Hyperphosphatemia); Roxadustat (Phase 3, Chronic Kidney Disease, Myelodysplastic Syndromes); Setidegrasib (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma)
Beijing InnoCare Pharma Tech Co.99693Fadeucravacitinib (Phase 3, Psoriasis); Mesutoclax (Phase 3, Acute Myeloid Leukemia, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia); Soficitinib (ICP-332) (Phase 3, Atopic Dermatitis, Psoriasis)
Betta Pharmaceuticals Co.3005583Befotertinib (Phase 3, Non-Small Cell Lung Cancer); Icotinib (Phase 3, Non-Small Cell Lung Cancer); Tibremciclib (Phase 3, HR+/HER2- Metastatic Breast Cancer)
BiohavenBHVN3Troriluzole (Phase 3, Spinocerebellar Ataxia); BHV-8000 (Phase 2/3, Parkinson's Disease); Opakalim (Phase 2/3, Epilepsy, Focal Onset Seizures)
China Medical System8673Desidustat (Phase 3, Chronic Kidney Disease); Piclidenoson (Phase 3, Psoriasis); CMS-D001 (Phase 2/3, Atopic Dermatitis, Psoriasis)
Gilead SciencesGILD3filgotinib (Phase 3, Rheumatoid Arthritis); Islatravir/lenacapavir (Phase 3, HIV); Quemliclustat (Phase 3, Pancreatic Ductal Adenocarcinoma)
Hangzhou Zhongmei Huadong Pharmaceutical0009633HDM1002 (Phase 3, Obesity, Type 2 Diabetes); janagliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease); VC005 (Phase 3, Atopic Dermatitis)
HK inno.N Corporation1959403Amlodipine/valsartan/atorvastatin (CJ-30061) (Phase 3, Atherosclerotic Cardiovascular Disease); Amlodipine/valsartan/rosuvastatin (CJ-30060) (Phase 3, Hypertension); AST-120 (Phase 3, Chronic Kidney Disease)
Luye Pharma Group21863Ansofaxine hydrochloride (Phase 3, Major Depressive Disorder); Evogliptin (Phase 3, Type 2 Diabetes); Rotigotine (LY03003) (Phase 3, Parkinson's Disease)
Otsuka Holdings45783OPC-61815 (Phase 3, Heart Failure); Tolvaptan (Phase 3, Heart Failure, Chronic Kidney Disease); Ulotaront (Phase 3, Schizophrenia, Generalized Anxiety Disorder)
Praxis Precision Medicines, Inc.PRAX3Relutrigine (Phase 3, Epilepsy, Developmental and Epileptic Encephalopathies); Ulixacaltamide (Phase 3, Essential Tremor); Vormatrigine (Phase 3, Epilepsy, Focal Onset Seizures)
Simcere Pharmaceutical20963Deulorlatinib (Phase 3, Non-Small Cell Lung Cancer); pumecitinib (Phase 3, Atopic Dermatitis); Zemprocitinib (Phase 3, Atopic Dermatitis, Rheumatoid Arthritis)
Advenchen Laboratories—2AL8326 (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer); Apatinib (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma)
Ahn-Gook Pharmaceutical0015402AG2304 (Phase 3, Atherosclerotic Cardiovascular Disease); AGSAVI (Phase 3, Hypertension)
AJU Pharm—2Dapagliflozin/linagliptin (Dapalina) (Phase 3, Type 2 Diabetes); Valsartan/amlodipine/chlorthalidone (AJU-C52) (Phase 3, Hypertension)
Arcus BiosciencesRCUS2Casdatifan (Phase 3, Clear Cell Renal Cell Carcinoma); Quemliclustat (Phase 3, Pancreatic Ductal Adenocarcinoma)
Ascletis Pharma16722ASC30 (Phase 3, Obesity, Type 2 Diabetes); Denifanstat (Phase 3, MASH / NASH, Recurrent Glioblastoma)
Avistone Biotechnology—2Andamertinib (Phase 3, Non-Small Cell Lung Cancer); Vebreltinib (Phase 3, Non-Small Cell Lung Cancer, Glioma, Non-Small Cell Lung Cancer with MET Exon 14 Skipping)
Axsome TherapeuticsAXSM2Esreboxetine (Phase 3, Fibromyalgia); Reboxetine (Phase 3, Narcolepsy)
BayerBAYN2Molidustat (Phase 3, Chronic Kidney Disease); Mosliciguat (Phase 3, Pulmonary Hypertension Associated with Interstitial Lung Disease)
BeBetter Med6887592BEBT-209 (Phase 3, HR+/HER2- Metastatic Breast Cancer, Breast Cancer); Ifupinostat (Phase 3, Multiple Myeloma, Relapsed/Refractory Diffuse Large B-Cell Lymphoma)
Boston Oncology—2Bireociclib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Dirozalkib (XZP-3621) (Phase 3, Non-Small Cell Lung Cancer)
Chengdu Kanghong Pharmaceutical0027732Cariprazine (Chengdu Kanghong) (Phase 3, Schizophrenia); KH607 (Phase 3, Major Depressive Disorder)
Chipscreen Biosciences6883212Chidamide (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Diffuse Large B-Cell Lymphoma and more); Chiglitazar (Phase 3, Type 2 Diabetes)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.—2Docetaxel (HB1801) (Phase 3, Non-Small Cell Lung Cancer, HER2-Positive Breast Cancer); Sirolimus for Injection (Albumin-bound) (Phase 3, HR+/HER2- Metastatic Breast Cancer)
Daiichi Sankyo45682Esaxerenone (Phase 3, Hypertension); Mirogabalin (Phase 3, Diabetic Peripheral Neuropathic Pain)
Dong-A ST1709002Evogliptin (Phase 3, Type 2 Diabetes); Udenafil (Phase 2/3, Pulmonary Arterial Hypertension)
Eurofarma Laboratorios—2Evogliptin (Phase 3, Type 2 Diabetes); Rizatriptan/naproxen (Phase 3, Migraine)
Exciva GmbH—2Deramciclane (Phase 2/3, Alzheimer's Disease); Deraphan (Phase 2/3, Alzheimer's Disease)
Genovate Biotechnology41302PMR (cilostazol ER) (Phase 3, Atherosclerotic Cardiovascular Disease); Prusogliptin (Phase 3, Type 2 Diabetes)
HLB Life Science0676302Apatinib (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma); Pyrotinib (Phase 3, Non-Small Cell Lung Cancer, HER2-Positive Breast Cancer)
HUYABIO International, LLC.—2Chidamide (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Diffuse Large B-Cell Lymphoma and more); JMKX001899 (Phase 3, Non-Small Cell Lung Cancer)
IncyteINCY2INCB123667 (Phase 3, Ovarian Cancer); INCB161734 (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma)
Innovent Biologics18012Limertinib (Phase 3, Non-Small Cell Lung Cancer); Olverembatinib (Phase 3, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Myeloid Leukemia with T315I Mutation)
Jacobio Pharmaceuticals11672Glecirasib (Phase 3, Non-Small Cell Lung Cancer); Sitneprotafib (Phase 3, Non-Small Cell Lung Cancer)
Jiangsu Aosaikang Pharmaceutical—2ASKC202 (Phase 3, Non-Small Cell Lung Cancer); Limertinib (Phase 3, Non-Small Cell Lung Cancer)
Kissei Pharmaceutical45472Mitiglinide (Phase 3, Type 2 Diabetes); Omarigliptin (Phase 3)
Kowa Company, Ltd.—2Anagliptin (Phase 3, Type 2 Diabetes); Pemafibrate (Phase 3, Atherosclerotic Cardiovascular Disease, Severe Hypertriglyceridemia, Hypertriglyceridemia and more)
Lee's Pharmaceutical09502Loxapine (Adasuve) (Phase 3, Schizophrenia, Bipolar Disorder); Istaroxime (Phase 2/3, Heart Failure, Cardiogenic Shock in Acute Heart Failure)
LG Chem0519102Besifovir dipivoxil (Besivo) (Phase 3, Chronic Hepatitis B); Gemigliptin (Phase 3, Type 2 Diabetes)
Neurocrine BiosciencesNBIX2Direclidine (Phase 3, Schizophrenia); Osavampator (Phase 3, Major Depressive Disorder)
NewAmsterdam PharmaNAMS2Obicetrapib (Phase 3, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, Early Alzheimer's Disease); Obicetrapib/ezetimibe (Evlarco) (Phase 3, Atherosclerotic Cardiovascular Disease)
Reistone Biopharma—2ivarmacitinib (Phase 3, Non-Radiographic Axial Spondyloarthritis); RSS0393 (Phase 3, Atopic Dermatitis, Psoriasis)
Sanwa Kagaku Kenkyusho—2Anagliptin (Phase 3, Type 2 Diabetes); Upacicalcet (Phase 3, Chronic Kidney Disease, Secondary Hyperparathyroidism)
Servier—2Darovasertib (Phase 3, Uveal Melanoma); Teneligliptin (Phase 3, Type 2 Diabetes)
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.6001962Foritinib succinate (Phase 3, Non-Small Cell Lung Cancer); Luvometinib (Phase 3, Non-Small Cell Lung Cancer, Glioma)
Shenzhen Salubris Pharmaceuticals0022942Enarodustat (Phase 3, Chronic Kidney Disease); SAL0120 (Phase 3, Hypertension, Chronic Kidney Disease)
Shionogi45072Dalcetrapib (Phase 3, Atherosclerotic Cardiovascular Disease); Enarodustat (Phase 3, Chronic Kidney Disease)
Sunshine Lake Pharma—2Clifutinib Besylate (Phase 3, Acute Myeloid Leukemia); Mitizodone phosphate (Phase 2/3, Major Depressive Disorder)
vTv TherapeuticsVTVT2cadisegliatin (Phase 3, Type 1 Diabetes); Prifemilast (HPP737) (Phase 3, Psoriasis)
Xuanzhu Biopharmaceutical25752Bireociclib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Dirozalkib (XZP-3621) (Phase 3, Non-Small Cell Lung Cancer)
Zydus LifesciencesZYDUSLIFE2Desidustat (Phase 3, Chronic Kidney Disease); Saroglitazar (Phase 3, Type 2 Diabetes, Hypertriglyceridemia, Primary Biliary Cholangitis)
Aardvark Therapeutics—1ARD-101 (Phase 3, Obesity, Prader-Willi Syndrome)
AB ScienceAB1Masitinib (Phase 3, Alzheimer's Disease, Asthma, Amyotrophic Lateral Sclerosis and more)
AbivaxABVX1obefazimod (Phase 3, Ulcerative Colitis, Crohn's Disease)
Acadia PharmaceuticalsACAD1Remlifanserin (Phase 3, Alzheimer's Disease, Alzheimer's Disease Psychosis)
Aclipse Therapeutics—1Lobeglitazone (Phase 3, Type 2 Diabetes)
Actinogen Medical (ASX: ACW)ACW1Emestedastat (Phase 2/3, Alzheimer's Disease, Major Depressive Disorder)
Addpharma—1AD-209 (Phase 3, Hypertension)
AffaMed Therapeutics—1fasedienol (Phase 3, Social Anxiety Disorder)
AgeneBio—1AGB101 (Phase 2/3, Alzheimer's Disease)
Agyany Pharma Ltd—1Ambroxol (Phase 3, Parkinson's Disease)
AirNexis Therapeutics—1HSK39004 (Phase 3, Chronic Obstructive Pulmonary Disease)
Aldeyra TherapeuticsALDX1reproxalap (Phase 3, Dry Eye Disease, Allergic Conjunctivitis)
Alebund Pharmaceuticals96371AP301 (fiber-iron phosphate binder) (Phase 3, Chronic Kidney Disease, Hyperphosphatemia)
Alfasigma—1filgotinib (Phase 3, Rheumatoid Arthritis)
Alkem LaboratoriesALKEM1Evogliptin (Phase 3, Type 2 Diabetes)
Alkermes plcALKS1Alixorexton (Phase 3, Narcolepsy, Idiopathic Hypersomnia)
AlmirallALM1Dimethyl fumarate (Skilarence) (Phase 3, Psoriasis)
Alpha Biopharma (Jiangsu) Co., Ltd.—1Zorifertinib (Phase 2/3, Non-Small Cell Lung Cancer)
AlumisALMS1Envudeucitinib (Phase 3, Psoriasis, Systemic Lupus Erythematosus)
AmgenAMGN1Bixalomer (Phase 3, Chronic Kidney Disease, Hyperphosphatemia)
Amorepacific—1asivatrep (Phase 3, Atopic Dermatitis)
Anavex Life SciencesAVXL1Blarcamesine (Phase 2/3, Alzheimer's Disease)
Angel Pharmaceuticals—1soquelitinib (Phase 3, Atopic Dermatitis, Peripheral T-Cell Lymphoma)
Annovis Bio (NYSE American: ANVS)ANVS1Buntanetap (Phase 3, Alzheimer's Disease, Parkinson's Disease, Early Alzheimer's Disease)
Apollomics Inc.APLM1Vebreltinib (Phase 3, Non-Small Cell Lung Cancer, Glioma, Non-Small Cell Lung Cancer with MET Exon 14 Skipping)
Aquestive Therapeutics, Inc.AQST1Diazepam (Libervant) (Phase 3, Epilepsy)
Arcera Life Sciences—1Enavogliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease)
AriBio—1AR1001 (Phase 3, Alzheimer's Disease)
Arog Pharmaceuticals, Inc.—1Crenolanib (Phase 3, Acute Myeloid Leukemia)
ArriVent BioPharmaAVBP1Furmonertinib (Phase 3, Non-Small Cell Lung Cancer)
Bausch HealthBHC1Rifaximin SSD (Phase 3)
Beijing Biostar Pharmaceuticals25631Utidelone (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer)
BeOne MedicinesONC1BGB-43395 (Phase 3, HR+/HER2- Metastatic Breast Cancer)
Beta Pharma, Inc.—1Rezivertinib (Phase 3, Non-Small Cell Lung Cancer)
BeyondSpring PharmaceuticalsBYSI1Plinabulin (Phase 3, Non-Small Cell Lung Cancer)
BioCity Biopharmaceutics—1SC0062 (Phase 3, Chronic Kidney Disease)
BiogenBIIB1BIIB122 / DNL151 (LRRK2 inhibitor) (Phase 3, Parkinson's Disease)
Biopeutics—1alprostadil (Phase 3, Heart Failure, Atherosclerotic Cardiovascular Disease)
BioVie Inc. (NASDAQ: BIVI)BIVI1Bezisterim (Phase 3, Alzheimer's Disease, Parkinson's Disease)
BioXcel Therapeutics, Inc.BTAI1Dexmedetomidine (Igalmi) (Phase 3, Schizophrenia, Bipolar Disorder, Alzheimer's Disease Agitation)
Boryung Pharmaceutical0038501Fimasartan/atorvastatin/ezetimibe (BR1017) (Phase 3, Hypertension, Atherosclerotic Cardiovascular Disease)
cAMPfield Therapeutics—1Prifemilast (HPP737) (Phase 3, Psoriasis)
Can-Fite BioPharmaCANF1Piclidenoson (Phase 3, Psoriasis)
CellCentric Ltd.—1Inobrodib (Phase 3, Acute Myeloid Leukemia, Multiple Myeloma)
Cerecin (Singapore, formerly Accera, Nestle Health Science-backed)—1Tricaprilin (Phase 3, Alzheimer's Disease)
Cerevance—1Solengepras (CVN424) (Phase 3, Parkinson's Disease)
Chendu DIAO Pharmaceutical Group—1DA-302168S (Phase 3, Obesity, Type 2 Diabetes)
Chengdu Easton Biopharmaceuticals—1Yogliptin (Phase 3, Type 2 Diabetes)
Chengdu Zenitar Biomedical Technology—1Purinostat Mesylate (Phase 3, Multiple Myeloma, Diffuse Large B-Cell Lymphoma)
Chia Tai Tianqing Pharmaceutical Group—1Lanifibranor (Phase 3, Type 2 Diabetes, MASH / NASH)
Chiesi Farmaceutici—1Beclomethasone dipropionate/formoterol fumarate (Phase 3, Chronic Obstructive Pulmonary Disease, Asthma)
China Resources Double-Crane Pharmaceutical6000621Gemigliptin (Phase 3, Type 2 Diabetes)
Chong Kun Dang Pharmaceutical1857501Lobeglitazone (Phase 3, Type 2 Diabetes)
CiplaCIPLA1Vildagliptin (Phase 3, Type 2 Diabetes)
Cogent Biosciences, Inc.COGT1bezuclastinib (Phase 3, Systemic Mastocytosis, Gastrointestinal Stromal Tumor)
COMPASS PathwaysCMPS1Psilocybin (COMP360) (Phase 3, Major Depressive Disorder, Post-Traumatic Stress Disorder)
Corvus PharmaceuticalsCRVS1soquelitinib (Phase 3, Atopic Dermatitis, Peripheral T-Cell Lymphoma)
Corxel Pharmaceuticals—1Omecamtiv mecarbil (Phase 3, Heart Failure, Heart Failure with Reduced Ejection Fraction)
CSPC Ouyi Pharmaceutical Co.—1SYHX1901 (Phase 3, Psoriasis)
Cullinan Therapeutics Inc.CGEM1Zipalertinib (Phase 3, Non-Small Cell Lung Cancer)
CytokineticsCYTK1Omecamtiv mecarbil (Phase 3, Heart Failure, Heart Failure with Reduced Ejection Fraction)
DalCor Pharmaceuticals—1Dalcetrapib (Phase 3, Atherosclerotic Cardiovascular Disease)
Definium TherapeuticsDFTX1Lysergide tartrate (LSD) (Phase 3, Major Depressive Disorder, Attention Deficit Hyperactivity Disorder, Generalized Anxiety Disorder)
Denali TherapeuticsDNLI1BIIB122 / DNL151 (LRRK2 inhibitor) (Phase 3, Parkinson's Disease)
Dermavon Holdings—1CMS-D001 (Phase 2/3, Atopic Dermatitis, Psoriasis)
Desitin Arzneimittel GmbH—1Piribedil (Clarium) (Phase 3, Parkinson's Disease)
Disc MedicineIRON1Bitopertin (Phase 3, Erythropoietic Protoporphyria)
Dr. Reddy's LaboratoriesRDY1Pyrotinib (Phase 3, Non-Small Cell Lung Cancer, HER2-Positive Breast Cancer)
EA Pharma—1Upacicalcet (Phase 3, Chronic Kidney Disease, Secondary Hyperparathyroidism)
Eccogene—1elecoglipron (Phase 3, Obesity, Type 2 Diabetes, Heart Failure and more)
Eikon TherapeuticsEIKN1Resiquimod (Phase 2/3, Non-Small Cell Lung Cancer, Melanoma)
Eisai45231Mitiglinide (Phase 3, Type 2 Diabetes)
Elevar Therapeutics, Inc.—1Apatinib (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma)
Eton Pharmaceuticals, Inc.ETON1Diazepam (Libervant) (Phase 3, Epilepsy)
Everest Medicines (Beijing) Co., Ltd.19521Sumecigrel (Phase 3, Atherosclerotic Cardiovascular Disease)
ExelixisEXEL1Zanzalintinib (Phase 3, Non-Small Cell Lung Cancer, Clear Cell Renal Cell Carcinoma, Colorectal Cancer and more)
Ferrer Internacional—1Loxapine (Adasuve) (Phase 3, Schizophrenia, Bipolar Disorder)
Fuji Pharma Co., Ltd.4554.T1Colestilan (Phase 3, Chronic Kidney Disease)
G42 Healthcare—1cadisegliatin (Phase 3, Type 1 Diabetes)
Gebro Pharma GmbH—1Piclidenoson (Phase 3, Psoriasis)
GenFleet Therapeutics25951GFH375 (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma)
Geropharm—1Evogliptin (Phase 3, Type 2 Diabetes)
Glenmark Pharmaceuticals Ltd.GLENMARK1Almonertinib (Phase 3, Non-Small Cell Lung Cancer)
GNT Biotech & Medicals—1Chidamide (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Diffuse Large B-Cell Lymphoma and more)
Gossamer BioGOSS1Seralutinib (Phase 3, Pulmonary Arterial Hypertension)
Grace TherapeuticsGRCE1Nimodipine (GTx-104) (Phase 3, Subarachnoid Hemorrhage)
Guangzhou JOYO Pharma—1Fudotinib (Phase 3, Non-Small Cell Lung Cancer)
H. LundbeckHLUN.B1Bexicaserin (Phase 3, Epilepsy)
Haihe Biopharma—1Glumetinib (Phase 3, Non-Small Cell Lung Cancer)
Handok0023901Teneligliptin (Phase 3, Type 2 Diabetes)
Hangzhou Highlightll Pharmaceutical—1BHV-8000 (Phase 2/3, Parkinson's Disease)
Harmony BiosciencesHRMY1Clemizole (EPX-100) (Phase 3, Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome)
Helus PharmaHELP1Deupsilocin (Phase 3, Major Depressive Disorder)
Henan Genuine Biotech—1Azvudine (Phase 3, HIV, COVID-19)
HighTide Biopharma25111Berberine ursodeoxycholate (HTD1801) (Phase 3, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease)
Hua Medicine25521Dorzagliatin (Phase 3, Type 2 Diabetes)
Huadong Medicine0009631Edaravone (TTYP01) (Phase 3, Alzheimer's Disease, Acute Ischemic Stroke)
HUTCHMEDHCM1Savolitinib (Phase 3, Non-Small Cell Lung Cancer, Renal Cell Carcinoma)
IDEAYA BiosciencesIDYA1Darovasertib (Phase 3, Uveal Melanoma)
IlDong Pharmaceutical Co., Ltd.2494201Besifovir dipivoxil (Besivo) (Phase 3, Chronic Hepatitis B)
Immuneering CorporationIMRX1Atebimetinib (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Cancer)
Immunome, Inc.IMNM1Varegacestat (Phase 2/3, Desmoid Tumors)
Inhibikase TherapeuticsIKT1Imatinib mesylate prodrug (IkT-001Pro) (Phase 3, Pulmonary Arterial Hypertension)
Intra-Cellular Therapies—1Deulumateperone (Phase 3, Alzheimer's Disease, Alzheimer's Disease Agitation, Generalized Anxiety Disorder)
InventivaIVA1Lanifibranor (Phase 3, Type 2 Diabetes, MASH / NASH)
InxMed—1Ifebemtinib (Phase 3, Non-Small Cell Lung Cancer)
Jazz PharmaceuticalsJAZZ1Cannabidiol (JZP926) (Phase 2/3, Epilepsy)
Jeil Pharmaceutical—1Pioglitazone (JT-001) (Phase 3, Type 2 Diabetes)
Jemincare—1JMKX001899 (Phase 3, Non-Small Cell Lung Cancer)
Ji Xing Pharmaceuticals (CORXEL)—1VCT220 (Phase 3, Obesity, Type 2 Diabetes, Hypertension)
Jiangsu Aidea Pharmaceutical Group—1ACC017 (Phase 3, HIV)
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.—1FHND9041 (Phase 3, Non-Small Cell Lung Cancer)
Jiangsu Vcare Pharmaceutical Technology Co., Ltd.—1Sumecigrel (Phase 3, Atherosclerotic Cardiovascular Disease)
Jiangsu Vcare Pharmatech—1VC005 (Phase 3, Atopic Dermatitis)
Jilin Huisheng Biopharmaceutical—1janagliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease)
Kailera TherapeuticsKLRA1Safiglipron (HRS-7535) (Phase 3, Obesity, Type 2 Diabetes, Hypertension and more)
Kaken Pharmaceutical45211Envudeucitinib (Phase 3, Psoriasis, Systemic Lupus Erythematosus)
KardiganKARD1Danicamtiv (Phase 3, Heart Failure)
Kind Pharmaceuticals—1AND017 (Phase 3, Chronic Kidney Disease, Myelodysplastic Syndromes)
Korea United Pharm0332701Cilostazol/rosuvastatin (UI022/UI023) (Phase 3, Atherosclerotic Cardiovascular Disease)
Kureha Corporation40231AST-120 (Phase 3, Chronic Kidney Disease)
Kyntra BioKYNB1Roxadustat (Phase 3, Chronic Kidney Disease, Myelodysplastic Syndromes)
Laboratoires SMB S.A.—1Pravafenix (Phase 3, Atherosclerotic Cardiovascular Disease, Hypertriglyceridemia)
Laekna Limited21051Afuresertib (Phase 3, HR+/HER2- Metastatic Breast Cancer)
LB PharmaceuticalsLBRX1LB-102 (methylated amisulpride) (Phase 3, Major Depressive Disorder, Schizophrenia)
Linnaeus Therapeutics, Inc.—1LNS8801 (Phase 2/3, Non-Small Cell Lung Cancer, Melanoma)
Liquidia CorporationLQDA1Treprostinil (L606) (Phase 3, Pulmonary Arterial Hypertension, Pulmonary Hypertension Associated with Interstitial Lung Disease)
Lynk Pharmaceuticals—1Zemprocitinib (Phase 3, Atopic Dermatitis, Rheumatoid Arthritis)
Maia BiotechnologyMAIA1Ateganosine (THIO) (Phase 3, Non-Small Cell Lung Cancer)
Matinas BioPharmaMTNB1Amphotericin B (MAT2203) (Phase 3, Cryptococcal Meningitis)
MediciNova, Inc.MNOV1Ibudilast (Phase 2/3, Asthma, Amyotrophic Lateral Sclerosis)
Medix—1Tesofensine (Phase 3, Obesity)
Meiji Seika Pharma—1Chidamide (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Diffuse Large B-Cell Lymphoma and more)
Mezzion Pharma1404101Udenafil (Phase 2/3, Pulmonary Arterial Hypertension)
MindRank AI—1MDR-001 (Phase 3, Obesity)
Mineralys TherapeuticsMLYS1Lorundrostat (Phase 3, Hypertension, Chronic Kidney Disease)
Minerva NeurosciencesNERV1Roluperidone (Phase 3, Schizophrenia)
MoleculinMBRX1Annamycin (Phase 2/3, Acute Myeloid Leukemia)
Nanjing Sanhome Pharmaceutical—1Rilertinib (SH-1028) (Phase 3, Non-Small Cell Lung Cancer)
NeuroDerm Ltd.—1Levodopa/carbidopa (ND0612) (Phase 3, Parkinson's Disease)
Newsoara Biopharma—1Prifemilast (HPP737) (Phase 3, Psoriasis)
Ningbo/Zhejiang Wenda Pharma Technology Co.—1WD-890 (Phase 3, Psoriasis)
Nizhpharm—1Chidamide (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Diffuse Large B-Cell Lymphoma and more)
Nordic Group B.V.—1S-1 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer, Gastric Cancer)
Nova Pneuma Inc.—1Staccato Alprazolam (Phase 3, Epilepsy)
NRx PharmaceuticalsNRXP1D-cycloserine/lurasidone (NRX-101) (Phase 3, Major Depressive Disorder, Bipolar Depression)
Nurix Therapeutics, Inc.NRIX1bexobrutideg (Phase 3, Chronic Lymphocytic Leukemia, Relapsed/Refractory Chronic Lymphocytic Leukemia)
Nuvalent, Inc.—1neladalkib (Phase 3, Non-Small Cell Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer)
Nuvation BioNUVB1safusidenib (Phase 3, Glioma)
Nxera Pharma45651Direclidine (Phase 3, Schizophrenia)
OCULAR THERAPEUTIX, INCOCUL1Axitinib intravitreal implant (OTX-TKI) (Phase 3, Age-Related Macular Degeneration, Wet Age-Related Macular Degeneration)
Olema Pharmaceuticals, Inc.OLMA1Palazestrant (Phase 3, HR+/HER2- Metastatic Breast Cancer)
Ono Pharmaceutical45281ONO-4578 (Phase 3, Non-Small Cell Lung Cancer, Gastric Cancer)
ORIC PharmaceuticalsORIC1Rinzimetostat (Phase 3, Prostate Cancer)
Orion CorporationORNBV1Levosimendan (Phase 3, Heart Failure, Pulmonary Hypertension due to Left Heart Disease)
Pathalys Pharma—1Upacicalcet (Phase 3, Chronic Kidney Disease, Secondary Hyperparathyroidism)
PegBio25651PB-201 (Phase 3, Type 2 Diabetes)
Pharma Two B Ltd.—1Pramipexole/rasagiline (P2B001) (Phase 3, Parkinson's Disease)
PharmaMarPHM1Plitidepsin (Phase 3, Multiple Myeloma)
Pharmanovia—1Diazepam (Libervant) (Phase 3, Epilepsy)
Pharmosa Biopharm Inc.68751Treprostinil (L606) (Phase 3, Pulmonary Arterial Hypertension, Pulmonary Hypertension Associated with Interstitial Lung Disease)
Population Council—1Dapivirine (Phase 3, HIV)
Prime Gene Therapeutics—1pumecitinib (Phase 3, Atopic Dermatitis)
Priothera SAS—1mocravimod (Phase 3, Acute Myeloid Leukemia)
Provectus PharmaceuticalsPVCT1rose bengal disodium (Phase 3, Locally Advanced Cutaneous Melanoma)
PTC TherapeuticsPTCT1Vatiquinone (PTC743) (Phase 3, Friedreich Ataxia)
Pulmovant—1Mosliciguat (Phase 3, Pulmonary Hypertension Associated with Interstitial Lung Disease)
Quetzal Therapeutics—1Arsenic trioxide (QTX-2101) (Phase 3, Acute Myeloid Leukemia)
Rapport Therapeutics, Inc.RAPP1RAP-219 (Phase 3, Epilepsy, Focal Onset Seizures)
Rednvia—1Evogliptin (Phase 3, Type 2 Diabetes)
Relay Therapeutics, Inc.RLAY1Zovegalisib (Phase 3, HR+/HER2- Metastatic Breast Cancer)
Revolution MedicinesRVMD1Zoldonrasib (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Cancer)
Risen (Suzhou) Pharma Tech Co., Ltd.—1JS105 (Phase 3, HR+/HER2- Metastatic Breast Cancer)
Roivant Sciences Ltd.ROIV1Mosliciguat (Phase 3, Pulmonary Hypertension Associated with Interstitial Lung Disease)
Sagimet Biosciences Inc.SGMT1Denifanstat (Phase 3, MASH / NASH, Recurrent Glioblastoma)
SanionaSANION1Tesofensine (Phase 3, Obesity)
SatRx—1Gosogliptin (Phase 3, Type 2 Diabetes)
SDK Therapeutics—1Arsenic trioxide (SDK001) (Phase 3, Acute Myeloid Leukemia)
Seismic Pharma—1Istaroxime (Phase 2/3, Heart Failure, Cardiogenic Shock in Acute Heart Failure)
SFA Therapeutics—1SFA-002 (Phase 2/3, Psoriasis)
Shanghai Auzone Biological Technology—1Edaravone (TTYP01) (Phase 3, Alzheimer's Disease, Acute Ischemic Stroke)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.6001961AR1001 (Phase 3, Alzheimer's Disease)
Shanghai Green Valley Pharmaceuticals—1Sodium oligomannate (Phase 3, Alzheimer's Disease)
Shanghai Henlius Biotech26961FHND9041 (Phase 3, Non-Small Cell Lung Cancer)
Shanghai Junshi Bioscience18771JS105 (Phase 3, HR+/HER2- Metastatic Breast Cancer)
Shanghai Longwood Biopharmaceuticals—1LW402 (Phase 3, Atopic Dermatitis)
Shanghai Pharmaceuticals Holding26071SPH4336 (Phase 2/3, HR+/HER2- Metastatic Breast Cancer)
Shenyang Sunshine Pharmaceutical—1Clifutinib Besylate (Phase 3, Acute Myeloid Leukemia)
Shenzhen TargetRx—1Deulorlatinib (Phase 3, Non-Small Cell Lung Cancer)
Shijiazhuang Yiling Pharmaceutical Co. Ltd0026031XY0206 (Phase 3, Acute Myeloid Leukemia)
Sihuan Pharmaceutical Holdings04601janagliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease)
SK Biopharmaceuticals Co., Ltd.3260301Carisbamate (Phase 3, Epilepsy)
SoligenixSNGX1Synthetic hypericin (Phase 3)
Specialised Therapeutics—1Plitidepsin (Phase 3, Multiple Myeloma)
Spinogenix—1Tazbentetol (SPG302) (Phase 2/3, Alzheimer's Disease, Schizophrenia, Amyotrophic Lateral Sclerosis)
STADA Arzneimittel—1Trigel (Phase 3, Parkinson's Disease)
Stendhal—1Gemigliptin (Phase 3, Type 2 Diabetes)
Structure TherapeuticsGPCR1aleniglipron (Phase 3, Obesity, Type 2 Diabetes)
Sumitomo Pharma45061Vildagliptin (Phase 3, Type 2 Diabetes)
Suven Life SciencesSUVEN1Masupirdine (Phase 3, Alzheimer's Disease)
Suzhou Puhe Pharmaceutical Technology Co., LTD—1Pruvonertinib (Phase 3, Non-Small Cell Lung Cancer)
Suzhou Zelgen Biopharmaceuticals6882661jaktinib (Phase 3, Atopic Dermatitis, Myelofibrosis, Alopecia Areata)
T's Pharma—1Voglibose (Phase 3, Type 2 Diabetes)
T3D Therapeutics—1T3D-959 (Phase 2/3, Alzheimer's Disease)
TauRx Therapeutics—1Hydromethylthionine mesylate (Phase 3, Alzheimer's Disease)
Teijin34011Trelagliptin (Phase 3, Type 2 Diabetes)
Tempest TherapeuticsTPST1Amezalpat (Phase 3, Hepatocellular Carcinoma)
Tenacia Biotechnology—1RAP-219 (Phase 3, Epilepsy, Focal Onset Seizures)
Tenax TherapeuticsTENX1Levosimendan (Phase 3, Heart Failure, Pulmonary Hypertension due to Left Heart Disease)
Teva Pharmaceutical IndustriesTEVA1Dexmedetomidine (Igalmi) (Phase 3, Schizophrenia, Bipolar Disorder, Alzheimer's Disease Agitation)
Tianjin Hemay Pharmaceutical—1Mufemilast (Phase 3, Ulcerative Colitis, Psoriasis)
TransThera Sciences (Nanjing), Inc.26171Tinengotinib (Phase 3, HR+/HER2- Metastatic Breast Cancer, Cholangiocarcinoma)
Trevi Therapeutics, Inc.TRVI1Nalbuphine ER (Phase 3, Prurigo Nodularis, Chronic Cough in Idiopathic Pulmonary Fibrosis)
TYK Medicines, Inc.24101Asandeutertinib (Phase 3, Non-Small Cell Lung Cancer)
UCBUCBJY1Staccato Alprazolam (Phase 3, Epilepsy)
United TherapeuticsUTHR1Ralinepag (Phase 3, Pulmonary Arterial Hypertension)
Vanda PharmaceuticalsVNDA1tradipitant (Phase 3, Gastroparesis)
Verastem, Inc.VSTM1GFH375 (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma)
Vertex PharmaceuticalsVRTX1Inaxaplin (Phase 2/3, Chronic Kidney Disease, APOL1-Mediated Kidney Disease)
Vifor Pharma—1Patiromer (Phase 3, Chronic Kidney Disease)
Vimgreen Pharmaceuticals—1VG081821AC (Phase 2/3, Parkinson's Disease)
Vincentage Pharma—1VCT220 (Phase 3, Obesity, Type 2 Diabetes, Hypertension)
Viriom—1Elsulfavirine (Phase 2/3, HIV)
VistaGen TherapeuticsVTGN1fasedienol (Phase 3, Social Anxiety Disorder)
VIVUS—1Extended-release tacrolimus (VI-0106) (Phase 3, Pulmonary Arterial Hypertension)
Wuhan Createrna Science and Technology—1QR12000 (Phase 3, Hypertension)
Xenon PharmaceuticalsXENE1Azetukalner (Phase 3, Major Depressive Disorder, Epilepsy, Focal Onset Seizures and more)
Yuhan Corporation0001001Sarpogrelate (Phase 3, Atherosclerotic Cardiovascular Disease)
Zeria Pharmaceutical Co., Ltd.45591Patiromer (Phase 3, Chronic Kidney Disease)
Zhejiang Hisun Pharmaceutical6002671Hyzetimibe (Phase 3, Atherosclerotic Cardiovascular Disease)
Zhimeng Biopharma—1CB03-154 (Phase 2/3, Epilepsy, Amyotrophic Lateral Sclerosis)

Stage is the furthest stage the drug has reached in any indication. Kind follows each drug's recorded modality; a drug whose modality is not recorded is left out.